Editorial Board Member
Linglong Zou
Director, Teva Pharmaceuticals, USA
About
As published by the journal they serve.
Linglong Zou is currently the Director of Experimental Immunology in Teva Pharmaceuticals. He graduated from Shanghai Institute of Materia Medica, Chinese Academy of Sciences with PhD in Pharmacology. He received postdoctoral training in Immunology, Neurology, Cell and Gene Therapy at Baylor College of Medicine. Linglong joined Teva in January 2012. In his current role, Linglong oversees immunogenicity assessment activities, including crafting immunogenicity assessment strategy, directing bioanalytical activities, interpreting immunogenicity data, and preparing regulatory filing and correspondence related to immunogenicity. Prior to Teva, he worked at two contract research organizations, including PRACS Institute as the Director of Ligand Binding Laboratory (2010-2011) and Bridge Laboratories as the Director of Immunology (2007-2010), where he directed bioanalytical method development, validation, and sample analysis activities for immunogenicity assessment, pharmacokinetic and pharmacodynamic analyses. From 2001 to 2007 he was Bioanalytical Scientist and Bioassay Group Leader at Tanox, Inc. (now Genentech Inc.) where he established a cell-based assay laboratory and developed assays to support potency and neutralizing antibody testing. He is an active member of American Association of Pharmaceutical Scientists. Over his industry career, he has contributed to approval of several biologics in US or EU markets.
Research interests
Journals they serve
The seats these journals name them in.
- Immunome ResearchEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
